Alzheimer's drug may slow the disease, but carries safety risk
WASHINGTON (AP) — Another experimental Alzheimer's drug can modestly slow patients' inevitable worsening — by about four to seven months, researchers reported Monday.
Eli Lilly and Co...
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login